PAVmed (PAVM) said Tuesday it regained compliance with Nasdaq's continued listing standards for primary equity securities.
The medical technology company said it received a notification on Friday from Nasdaq stating its securities will continue to be listed and traded on the stock exchange.
PAVmed will be under a mandatory panel monitor for one year, during which any failure to meet stockholders' equity requirements will trigger a delisting notice, requiring immediate action and possibly a new hearing, the company said.
Shares of PAVmed were up nearly 6% in recent Tuesday trading.
Price: 0.84, Change: +0.05, Percent Change: +5.95
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。